MoU between Swedish and Indonesian Life Science Industry Organisations
Press Release • May 27, 2013 09:00 EDT
On the 27th
of May, in conjunction with the Indonesian state visit to Sweden, a Memorandum of Understanding was signed between
the leading life-sciences industry
and Indonesian Pharmaceutical Association.
A Memorandum of Understanding, was signed by Johannes Setijono, Chairman of the Indonesian Pharmaceutical Association and Kalbe Farma, Lars Adlersson, Vice Chairman of SwedenBIO and Niclas Adler Chairman of the newly initiated Indonesian International Institute for Life Sciences (i3L), to explore creating a sustainable and mutually beneficial collaboration between the Swedish and Indonesian Life Science industry.
The signing took place at Business Sweden, the Swedish Trade and Investment Council, hosted by the Vice Chairman, Anders Hallersjö and under the supervision of Ewa Polano, the Swedish Ambassador to Indonesia.
“Relations between Sweden and Indonesia are blooming right now, and we should take advantage of the opportunities available in forth largest country in the world with a rapidly growing middle class, seeking new treatment options and accessibility to better healthcare,” says Ewa Polano. A future collaboration will have a significant positive impact on patient populations, research and innovation, and life-science companies in both countries.
Indonesia is one of the largest and fastest-growing countries in the world and is seeking treatment options for its population through a forward-thinking policy. Sweden is one of the world leaders in life science innovation and will benefit from systematic access to larger and more diverse ecosystems to further tailor Swedish technologies. A future collaboration will have a significant positive impact on patient populations, research and innovation, and life-science companies in both countries.
The intention of the proposed collaboration is to explore innovation and commercialization projects within life science industry to benefit from the complementary strengths and opportunities in Sweden and Indonesia. To that end, the signatories have agreed to identify the needs of SMEs, respective life-science industry actors, and the life-science innovation systems in both countries, to enable the stakeholders to build a truly translational platform for research & development and commercialization collaboration.
“The Indonesian Pharmaceutical Association take great pleasure in initiating in this exciting collaboration together with SwedenBIO and i3L,” expressed Johannes Setijono after the signing.
To facilitate the cooperation and strengthen the execution capacity of the intended collaboration, the Indonesian Life Science Institute i3L, will help create sustainable models that can accelerate research, innovation and commercialization of projects between the two countries.
Both parties have initiated a search for counterparts within specific therapeutic areas and will promote the Swedish/Indonesian life-science opportunity at workshops and during the international partner- invest- and network meeting Nordic Life Science Days in Stockholm, October 14-15.SwedenBIOSwedenBIO is a leading industry association that aims to improve the business climate for its 200 member companies as well as the wider life sciences industry in Sweden, closely collaborating with relevant national and international stakeholders. In addition to advocacy and promotion of industry interests, SwedenBIO enables professional development, knowledge, and experience exchange through its member services. Last year, SwedenBIO celebrated its 10 years anniversary. www.swedenbio.com
Indonesian Pharmaceutical Association (GP. Farmasi Indonesia)
The Indonesian Pharmaceutical Association was established on August 19, 1969 to represent the entire Indonesian Pharmaceutical industry. The organization promotes communication and consultation between the Indonesian pharmaceutical industry, government and other parties concerned with issues relating to the production of drugs, distribution and life science services. www.gpfarmasi.orgIndonesia International Institute for Life-Sciences (i3L)
i3L is a pioneering initiative to generate critical mass and accelerate research, education and innovation activity within the South-East Asian Life-sciences eco-system. The institute was founded with donations from the founders of Kalbe Farma (www.kalbe.co.id), Indonesia’s largest pharmaceutical company, with strong support from the Indonesian Ministry of Science and Technology, as well as Ministry for Education, Ministry for Health, and prominent key opinion leaders internationally.
+46 70 420 33 74
firstname.lastname@example.org Prof. Niclas Adler
+46 761 680750
SwedenBIO helps innovative companies succeed! SwedenBIO is the national organization working for the benefit of the entire life science sector in Sweden - a member driven, private non-profit organization. The main objective is to improve and maintain industry conditions which will support prosperous growth and business development among our, today, close to 200 member companies. Our members are active in the fields of pharmaceutical, biotech, medtech and diagnostics. Our mission is to create visibility and interest for the Swedish life science and thereby support a successful life science industry. A successful industry can heal and help those patients still suffering from unmet medical needs. A successful industry creates jobs and welfare and creates opportunities for a healthier and brighter future. We’ve been successfully doing this for 10 years.